3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
78
Carcinoma, Non-Small-Cell Lung
43
Nasopharyngeal Carcinoma
24
Lung Neoplasms
23
Breast Neoplasms
14
Cholangiocarcinoma
13
Lymphoma, Large B-Cell, Diffuse
12
Neoplasm Metastasis
11
Ovarian Neoplasms
10
Lymphoma, Extranodal NK-T-Cell
10
Recurrence
9
Biliary Tract Neoplasms
9
Urinary Bladder Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasms
6
Nasopharyngeal Neoplasms
6
Lymphoma
6
Lymphoma, T-Cell, Peripheral
5
Uterine Cervical Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
4
Rectal Neoplasms
4
Hodgkin Disease
4
Head and Neck Neoplasms
4
Gallbladder Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Transitional Cell
4
Adenocarcinoma of Lung
4
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, T-Cell
3
Interventions
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Gemcitabine
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Metastatic Pancreatic Adenocarcinoma
×
Gemcitabine
×
Clear all
NCT01729481
2017-07-19
ML22774
Ludwig-Maximilians - University of Munich
Phase 2
Unknown
150 enrolled